vascepa

  1. An Analytical Analysis of Vascepa®

    An Analytical Analysis of Vascepa® (Icosapent Ethyl) Fatty Acid Composition with Comparison to Advertised Ingredient Claims and Fatty Acid Profiles of Lovaza® and Nature’s Bounty® Fish Oil. Introduction: FDA-approved Vascepa is prescribed to patients with hypertriglyceridemia to reduce high...
  2. Fort Myers Rep Position open

    I asked some of my drs and they said Vascepa is a great drug, good commercial coverage, but expensive for Medicare. In SWFL, Medicare is everything for your business. Can you meet your sales goals? Is the manager a good manager? Are you measured on TRX, NRX or NBRX? How big is the territory...
  3. Amarin will bounce back

    I expect that Amarin will bounce back from the recent sell-off. Most of the doctors who participated in the AHA event has said that they will prescribe Vascepa and next year the biggies like Pfizer might considering acquiring Amarin...
  4. Will Pfizer buy Amarin?

    There are rumors that Pfizer would take over Amarin, which skyrocketed today in the stock market as the cardiovascular study met primary and secondary endpoints using Vascepa drug. But Amarin has said that it's just a speculation...